✦ LIBER ✦

A Randomized Phase 2 Trial of Bevacizumab with or without Daily Low-Dose Interferon Alfa-2b in Metastatic Malignant Melanoma

✍ Scribed by Kimberly A. Varker; Jennifer E. Biber; Cheryl Kefauver; Rhonda Jensen; Amy Lehman; Donn Young; Haifeng Wu; Gregory B. Lesinski; Kari Kendra; Helen X. Chen; Michael J. Walker; William E. Carson III

Book ID: 111772012
Publisher: Springer
Year: 2007
Tongue: English
Weight: 259 KB
Volume: 14
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-007-9389-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical phase II trial of recombinant d

Clinical phase II trial of recombinant dna interferon (interferon alfa 2b) in patients with metastatic malignant melanoma

✍ Thierry Dorval; Thao Palangie; Michel Jouve; Emilio Garcia-Giralt; Lucien Israel 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 3 views

A randomized trial of high dose interfer

A randomized trial of high dose interferon alfa-2b with or without ribavirin for chronic hepatitis C in non-responders to standard dose interferon

✍ Shiva Kumar, K.; Malik, Arshad H.; Malet, Peter F.; Ostapowicz, George; Wood, Me 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Improved tolerability and quality of lif

Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-α-2b : Results of a randomized phase II trial of low-dose versus intermediate-dose interferon-α-2b in patients with metastatic renal cell carcinoma

✍ Nizar M. Tannir; Lorenzo Cohen; Xuemei Wang; Peter Thall; Paul F. Mathew; Eric J 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

A multinational phase II trial of bevaci

A multinational phase II trial of bevacizumab with low-dose interferon- 2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN

✍ Melichar, B.; Bracarda, S.; Matveev, V.; Alekseev, B.; Ivanov, S.; Zyryanov, A.; 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 191 KB

463 oral A phase II trial combining low-

463 oral A phase II trial combining low-dose total body irradiation and intereukin-2 in patients with metastatic malignant melanoma

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Response to higher doses of interferon a

Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: A randomized multicenter trial

✍ K L Lindsay; G L Davis; E R Schiff; H C Bodenheimer; L A Balart; J L Dienstag; R 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

JANICE ALBRECHT, 12 AND THE HEPATITIS INTERVENTIONAL THERAPY GROUP\* with continued therapy at that dose; however, a propor-To evaluate response rates to 3, 5, or 10 million units tion of patients who do not respond to 12 weeks of treat-(MU) of interferon alfa-2b, given thrice weekly, and to ment wi